MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Disposal Requirements
20 questions · exam conditions
0:00
Disposal RequirementsQuestion 1 of 20

The DEA hosted a National Prescription Drug Take Back event in a pharmacy's community. The pharmacy wants to participate by staffing an off-site collection location during the event. Under what authority may the pharmacy participate?

Pharmacies may participate by partnering with the DEA for sanctioned Take Back events under applicable regulations.
Pharmacies may not participate in Take Back events because collection authority is limited to law enforcement agencies.
Pharmacies may participate only if they have been permanent authorized collectors for at least one year.
Pharmacies may participate without any DEA coordination by simply accepting drugs from the public at any location.
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Disposal Requirements

Practice Disposal Requirements in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Disposal Requirements, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

The DEA hosted a National Prescription Drug Take Back event in a pharmacy's community. The pharmacy wants to participate by staffing an off-site collection location during the event. Under what authority may the pharmacy participate?

  1. Pharmacies may participate by partnering with the DEA for sanctioned Take Back events under applicable regulations. (correct answer)
  2. Pharmacies may not participate in Take Back events because collection authority is limited to law enforcement agencies.
  3. Pharmacies may participate only if they have been permanent authorized collectors for at least one year.
  4. Pharmacies may participate without any DEA coordination by simply accepting drugs from the public at any location.
Explanation: DEA National Prescription Drug Take Back events allow DEA-approved entities including pharmacies to participate as collection partners under the take-back event framework. This provides a temporary collection mechanism separate from permanent authorized collector status. A correctly describes this participation pathway. B is incorrect because pharmacies are recognized participants in DEA Take Back events. C is incorrect because prior authorized collector status is not required for take-back event participation. D is incorrect because take-back collection must be conducted under DEA authorization and coordination, not independently.

Question 2

A pharmacy receives a notice that a controlled substance product it has in inventory has been recalled. After quarantining the recalled stock, what is the appropriate disposal pathway for the recalled controlled substances?

  1. Recalled controlled substances must be disposed of through DEA-authorized methods, such as reverse distribution or manufacturer return with authorization. (correct answer)
  2. Recalled controlled substances may be discarded in the regular trash because the recall notice supersedes DEA disposal requirements.
  3. Recalled controlled substances are automatically returned to the manufacturer without DEA documentation.
  4. Recalled controlled substances may be flushed down the drain as an emergency disposal measure.
Explanation: Recalled controlled substances must still follow DEA-authorized disposal pathways regardless of the reason for recall. Options include transfer to a reverse distributor, authorized return to the manufacturer, or DEA-approved on-site destruction. A correctly identifies these requirements. B is incorrect because a recall notice does not override DEA disposal requirements. C is incorrect because manufacturer returns of controlled substances require DEA documentation. D is incorrect because drain disposal is not an authorized method for pharmacy registrant disposal of recalled controlled substances.

Question 3

A pharmacy receives a shipment of controlled substances that are damaged and cannot be dispensed. The pharmacy wants to return them to the manufacturer rather than using a reverse distributor. What documentation is required for this return shipment?

  1. DEA Form 222 or CSOS is required for returning Schedule I and II controlled substances. (correct answer)
  2. No documentation is required because damaged returns are considered a routine business transaction.
  3. Only the pharmacy's purchase invoice from the original shipment is needed.
  4. The pharmacy must obtain a DEA variance before returning any damaged controlled substances to a manufacturer.
Explanation: Returning controlled substances to a manufacturer requires appropriate documentation. Schedule I and II returns require a DEA Form 222 or CSOS equivalent; the transfer must be documented and records retained. A correctly identifies this requirement. B is incorrect because damaged returns are not documentation-exempt. C is incorrect because the original purchase invoice alone does not satisfy the DEA transfer documentation requirement. D is incorrect because a DEA variance is not the standard mechanism for a manufacturer return of damaged product.

Question 4

A pharmacy's DEA-registered reverse distributor has confirmed receipt of controlled substances for disposal but has not yet completed the actual destruction. The pharmacy asks when it may update its controlled substance inventory records. Which of the following best applies?

  1. The pharmacy may not update its records until it has received confirmation that destruction has been completed.
  2. The pharmacy may update its inventory records upon transfer to the reverse distributor because the pharmacy's custody and responsibility for the substances ends at transfer. (correct answer)
  3. The pharmacy may update its records only after the DEA has confirmed the destruction.
  4. The pharmacy may never update its inventory records for transferred substances; they remain on the pharmacy's records permanently.
Explanation: Once a pharmacy transfers controlled substances to a DEA-registered reverse distributor, custody and responsibility for those substances transfer. The pharmacy may update its inventory records at the time of transfer. B correctly identifies when the inventory update is appropriate. A is incorrect because awaiting destruction confirmation before inventory update is overly conservative; transfer ends the pharmacy's custody. C is incorrect because DEA confirmation is not required before the pharmacy updates its inventory upon transfer. D is incorrect because transferred substances must be removed from the pharmacy's active inventory records.

Question 5

A state pharmacy law requires pharmacies to report all controlled substance destruction events to the state board of pharmacy within 30 days. DEA Form 41 has already been submitted to the DEA. Does the pharmacy also need to report to the state board?

  1. Yes, state and federal reporting obligations are independent; submitting DEA Form 41 satisfies the federal requirement, but the pharmacy must also separately comply with the state board reporting requirement. (correct answer)
  2. No, submitting DEA Form 41 automatically satisfies all state reporting requirements because federal law preempts state drug destruction reporting.
  3. No, only one report is required; the pharmacy may choose either the DEA or state board and submit to just one.
  4. No, state board reporting is only required when destruction is witnessed by law enforcement.
Explanation: State and federal reporting obligations for controlled substance destruction operate independently. Filing DEA Form 41 satisfies the federal DEA requirement; the pharmacy must also comply with any applicable state board reporting requirement. A correctly identifies this dual obligation. B is incorrect because federal law does not preempt state pharmacy board reporting requirements for controlled substance destruction. C is incorrect because the pharmacy may not choose one over the other when both are required by applicable law. D is incorrect because state board reporting requirements are not conditioned on law enforcement witness presence.

Question 6

A patient asks the pharmacist whether she can bring unused opioids from a deceased family member to the pharmacy for disposal. Which of the following best describes the pharmacist's response at a pharmacy that is an authorized collector?

  1. The pharmacy may only accept controlled substances from the patient herself; controlled substances belonging to a deceased person cannot be accepted.
  2. The pharmacy may accept unused opioids from family members of a deceased person as they are considered ultimate users under DEA rules. (correct answer)
  3. The pharmacy must require a death certificate before accepting any controlled substances from a deceased person's estate.
  4. The pharmacy must contact the DEA regional office for authorization before accepting controlled substances from a deceased person's estate.
Explanation: DEA regulations define ultimate users to include family members or persons responsible for the care of a person who possessed controlled substances. Family members of a deceased individual are authorized to surrender those controlled substances to an authorized collector. B correctly identifies this provision. A is incorrect because DEA regulations specifically authorize family members and caregivers to surrender controlled substances belonging to deceased persons. C is incorrect because a death certificate is not required under DEA regulations for acceptance at an authorized collector. D is incorrect because prior DEA authorization is not required for each individual authorized collector transaction.

Question 7

A patient asks a pharmacist what she should do with unused opioid pain tablets at home when no take-back location is available in her area. Which of the following best describes the FDA and DEA guidance for ultimate users in this situation?

  1. Store them indefinitely in a locked cabinet because disposal without a take-back program is prohibited.
  2. Mix with undesirable substance, seal in container, dispose in trash; flush if on FDA flush list. (correct answer)
  3. Return them to the pharmacy, which must accept them regardless of whether it is an authorized collector.
  4. Crush the tablets and pour them down the drain because liquefied medications are always safe to flush.
Explanation: FDA and DEA guidance for ultimate users who cannot access a take-back program permits mixing medications with coffee grounds, kitty litter, or another undesirable substance and disposing in household trash; certain medications on the FDA flush list may also be flushed when take-back is unavailable. B correctly describes this guidance. A is incorrect because indefinite home storage of unused controlled substances is not recommended and disposal is encouraged. C is incorrect because pharmacies are not required to accept patient medications unless they are authorized collectors. D is incorrect because crushing tablets does not create an FDA-flushing exception; the flush list governs which specific medications may be flushed.

Question 8

A retail pharmacy has become an authorized collector under DEA regulations and has placed a take-back collection receptacle in its waiting area. Which of the following best describes the compliance requirements for the collection receptacle?

  1. The collection receptacle must be securely locked, mounted, and only accessible for removal by authorized personnel. (correct answer)
  2. The collection receptacle may be any locked container placed in the waiting area.
  3. The collection receptacle must be supervised by a pharmacist at all times while it is accessible to the public.
  4. The collection receptacle contents may be sorted by the pharmacy and non-controlled items discarded separately from controlled substances.
Explanation: DEA authorized collector collection receptacles must meet specific construction and security requirements under 21 CFR 1317. The inner liner must be sealed and sent to a destruction facility; the pharmacy cannot open the receptacle to sort or review contents. A correctly identifies these requirements. B is incorrect because DEA specifications for construction and security must be met. C is incorrect because constant pharmacist supervision is not required for a properly secured collection receptacle. D is incorrect because the pharmacy may not open or sort the receptacle contents.

Question 9

A pharmacy is an authorized collector under DEA regulations and wants to participate in a mail-back program for patient drug disposal of controlled substances. Under DEA regulations, which of the following best describes how a controlled substance mail-back program must be structured?

  1. Authorized collectors provide DEA-approved, pre-paid, tamper-evident packages for patients to mail drugs to registered addresses for disposal. (correct answer)
  2. Patients may mail controlled substances using any standard postal service envelope addressed to the nearest DEA field office.
  3. Mail-back packages go directly to an FDA-licensed destruction facility chosen by the patient.
  4. The pharmacy creates its own mail-back envelopes and has patients mail controlled substances directly to the pharmacy's dispensing window.
Explanation: Under DEA regulations governing authorized collectors, controlled substance mail-back programs use DEA-approved, tamper-evident, pre-paid packages provided by the authorized collector to ultimate users. Patients place controlled substances in the sealed package and mail it to the authorized collector's registered address or another authorized destination specified by the program; the authorized collector then disposes of received substances through a DEA-authorized disposal method. A correctly describes this structure. B is incorrect because DEA field offices are not the proper destination for mail-back packages, and ordinary postal envelopes are not authorized packaging. C is incorrect because patients do not choose an FDA-licensed destruction facility; collected substances go to the authorized collector first. D is incorrect because pharmacies may not create their own unofficial mail-back envelopes; DEA-approved packaging and program requirements must be followed.

Question 10

A hospice patient has passed away and the hospice nurse is present in the home with remaining controlled substance medications. Under DEA regulations, what may the hospice nurse do with these medications?

  1. The hospice nurse may take the medications and return them to the hospice organization's pharmacy.
  2. The hospice nurse may assist in disposing of the medications in accordance with DEA and state regulations. (correct answer)
  3. The hospice nurse must contact the DEA regional office for disposal instructions before touching the medications.
  4. The hospice nurse must leave the medications in the home because only family members may handle a deceased person's controlled substances.
Explanation: DEA regulations specifically authorize hospice personnel to witness and dispose of controlled substances belonging to deceased hospice patients in the home setting. B correctly identifies this DEA authorization. A is incorrect because returning controlled substances to the hospice pharmacy is not an authorized method for home disposal by a nurse. C is incorrect because DEA regional office contact is not required before a hospice nurse exercises her disposal authority. D is incorrect because DEA regulations specifically authorize hospice personnel, not only family members, to handle this disposal.

Question 11

An automated dispensing cabinet (ADC) in a hospital has waste controlled substance residuals -- for example, partial doses wasted after administering to a patient. Which of the following best describes the required disposal process for these waste residuals?

  1. ADC waste residuals may be discarded in regular garbage because they are clinical waste.
  2. ADC waste residuals are automatically accounted for by the ADC software and require no additional documentation.
  3. ADC waste residuals must be documented and witnessed to comply with DEA and hospital policy requirements. (correct answer)
  4. ADC waste residuals must be flushed immediately without documentation.
Explanation: DEA regulations require controlled substances to be fully accounted for, meaning any wasted residual must be documented in a manner that reconciles quantities dispensed, administered, and wasted. Hospital policy and most state regulations further specify that the wasting must be witnessed contemporaneously and that documentation capture the drug, amount, patient, date and time, and the identities of the wasting individual and witness. C correctly describes these combined obligations. A is incorrect because ADC waste residuals are controlled substances subject to DEA accounting requirements and cannot be discarded as ordinary clinical waste. B is incorrect because ADC software records dispenses but does not substitute for the required human documentation of the actual amount wasted for each dose. D is incorrect because flushing without documentation does not satisfy DEA accounting requirements and destroys the waste record.

Question 12

A pharmacy's pharmacist-in-charge wants to dispose of an unusable controlled substance patch that was removed from a patient at the hospital. Which of the following best describes a compliant disposal method?

  1. Place the patch in the regular medical waste container because it is a used product.
  2. Return the patch to the manufacturer for disposal.
  3. Give the patch to the patient to take home for disposal.
  4. Dispose of the patch through a DEA-authorized reverse distributor or on-site destruction method. (correct answer)
Explanation: A hospital pharmacy is a DEA registrant and must dispose of controlled substance waste -- including returned used patches -- through DEA-authorized registrant disposal pathways, such as DEA-authorized on-site destruction or transfer to a licensed reverse distributor, with required documentation. Folding the patch sticky-side in reduces residual drug exposure risk during handling. The FDA flush list applies to ultimate users (patients/caregivers) who lack access to a take-back program, not to DEA-registered pharmacy practitioners managing clinical waste. A is incorrect because regular medical waste disposal does not satisfy DEA controlled substance disposal requirements for a registrant. B is incorrect because returning a used patch to the manufacturer is not a standard DEA-authorized disposal pathway for clinical waste. C is incorrect because giving a used controlled substance patch to a patient is not compliant disposal.

Question 13

A pharmacist discovers that a DEA Form 41 submitted for a batch of destroyed controlled substances contains an error -- the quantity listed is 50 tablets instead of 500. The destruction has already been completed. What is the appropriate course of action?

  1. File a new DEA Form 41 with the correct quantity and retain both the original and corrected forms.
  2. Erase the error and write in the correct quantity to maintain a clean record.
  3. Annotate the original form with the correct quantity, date, and identity of the person making the correction. (correct answer)
  4. The error is immaterial because destruction has been completed and no correction is needed.
Explanation: When a material error is discovered in a completed controlled substance destruction record, the appropriate approach is to make a clearly annotated correction without altering or erasing the original entry, document the correct information alongside the original, and retain both. This preserves the integrity of the original record while creating a transparent correction trail. Consulting DEA guidance or the DEA field office is appropriate when the discrepancy is significant enough to raise diversion concerns, but this is a practical step rather than a universally mandated regulatory requirement. A is incorrect because filing an entirely new Form 41 without annotation on the original creates conflicting records without explaining the discrepancy. B is incorrect because erasing and rewriting an official controlled substance record constitutes falsification regardless of intent. D is incorrect because a tenfold quantity discrepancy is a material error that must be corrected and documented.

Question 14

A pharmacy that is not a DEA authorized collector receives a patient's unused opioids brought in for disposal. The pharmacist accepts the medications out of compassion. Which of the following best describes the compliance concern?

  1. There is no compliance concern because the patient's intent was proper and the pharmacist acted compassionately.
  2. There is no compliance concern as long as the pharmacist disposes of the medications using the pharmacy's existing controlled substance disposal process.
  3. Accepting controlled substances for disposal without DEA collector authorization violates regulations. (correct answer)
  4. There is no compliance concern if the controlled substances were not in original containers.
Explanation: Only DEA authorized collectors may accept controlled substances from ultimate users for disposal. A pharmacy that is not an authorized collector accepting patient medications violates DEA regulations regardless of compassionate intent. C correctly identifies this violation. A is incorrect because compassionate motivation does not create regulatory authorization. B is incorrect because using the pharmacy's existing disposal process for unauthorized patient surrenders does not cure the authorization deficiency. D is incorrect because container status is irrelevant to whether the pharmacy is authorized to accept the medications.

Question 15

A hospital pharmacy needs to dispose of expired Schedule II controlled substances. The hospital is not an authorized collector and does not have an on-site destruction program. Which of the following is the most appropriate disposal pathway?

  1. Pour the substances down the hospital's industrial drain system, which is considered compliant for institutional use.
  2. Transfer the substances to the hospital's hazardous waste disposal vendor without DEA documentation.
  3. Incinerate the substances along with regular medical waste without DEA involvement.
  4. Send the substances to a DEA-registered reverse distributor with proper documentation of transfer. (correct answer)
Explanation: For a hospital without an on-site destruction program or authorized collector status, the appropriate pathway for Schedule II disposal is transfer to a DEA-registered reverse distributor with full documentation. D correctly identifies this pathway. A is incorrect because drain disposal is not an authorized method for hospital pharmacy registrant disposal of Schedule II controlled substances. B is incorrect because transfer to a hazardous waste vendor without DEA documentation does not satisfy controlled substance disposal requirements. C is incorrect because incineration with regular medical waste without DEA authorization is not compliant.

Question 16

Under DEA regulations, which of the following is a DEA-authorized method for a retail pharmacy to dispose of expired or unwanted controlled substances?

  1. Transferring the controlled substances to a DEA-registered reverse distributor authorized to handle controlled substance disposal. (correct answer)
  2. Flushing all controlled substances down the drain, which is considered the most environmentally responsible method.
  3. Placing controlled substances in the regular trash with no special precautions as long as the labels are removed.
  4. Transferring the controlled substances to any licensed pharmacist who agrees to accept them.
Explanation: Under DEA regulations, one authorized disposal method for pharmacies is transferring controlled substances to a DEA-registered reverse distributor that is authorized to receive and handle controlled substance disposal. A correctly identifies this authorized method. B is incorrect because flushing is not a DEA-authorized standard disposal method for pharmacies; it is permitted only as a last resort in specific circumstances and is generally environmentally discouraged. C is incorrect because placing controlled substances in regular trash without special precautions is not an authorized DEA disposal method. D is incorrect because transfer to an arbitrary licensed pharmacist does not satisfy DEA disposal regulations.

Question 17

A pharmacy wants to establish an on-site destruction program to dispose of controlled substances without using a reverse distributor. What DEA authorization is required for on-site destruction?

  1. No authorization is needed; pharmacies may destroy controlled substances on site at any time.
  2. DEA prior authorization is required for on-site destruction of controlled substances. (correct answer)
  3. On-site destruction is authorized automatically when a pharmacy holds a DEA registration.
  4. On-site destruction requires only state board of pharmacy approval.
Explanation: DEA regulations require prior DEA authorization for an on-site controlled substance destruction program. Destruction must occur using an authorized method, witnessed appropriately, with all required documentation completed. B correctly identifies these requirements. A is incorrect because unrestricted on-site destruction without authorization is not permitted. C is incorrect because holding a DEA registration does not automatically authorize an on-site destruction program. D is incorrect because state board approval alone does not satisfy the federal DEA authorization requirement.

Question 18

When a pharmacy transfers controlled substances to a DEA-registered reverse distributor for disposal, what records must the pharmacy maintain?

  1. No records are required because the reverse distributor assumes all recordkeeping responsibility upon transfer.
  2. Only the weight of the controlled substances transferred.
  3. Only the drug names and the date of transfer.
  4. Maintain records of the reverse distributor's details and an inventory of transferred controlled substances. (correct answer)
Explanation: When transferring controlled substances to a reverse distributor, the pharmacy must maintain complete transfer records including the reverse distributor's identity and DEA registration number and a full inventory of what was transferred. D correctly identifies these recordkeeping obligations. A is incorrect because both the pharmacy and the reverse distributor have recordkeeping obligations; the pharmacy's obligation does not transfer with the drugs. B is incorrect because weight alone is insufficient to identify what was transferred. C is incorrect because drug names and date alone omit other required elements.

Question 19

What documentation must a DEA-registered reverse distributor provide to a pharmacy after completing controlled substance destruction?

  1. No documentation is required because destruction is the reverse distributor's sole responsibility.
  2. A receipt of acceptance is sufficient; no destruction documentation is required.
  3. A destruction confirmation document detailing drug identity and quantities destroyed. (correct answer)
  4. The reverse distributor must notify the DEA only; the pharmacy receives no documentation.
Explanation: After completing controlled substance destruction, the reverse distributor is responsible for filing required DEA documentation and maintaining records of the destruction. The pharmacy should receive confirmation from the reverse distributor that the transferred substances were destroyed, with sufficient detail to support the pharmacy's own controlled substance accounting records. DEA regulations do not expressly require the reverse distributor to provide the pharmacy a copy of DEA Form 41 specifically, but the pharmacy must be able to document the transfer and disposition in its own records. A is incorrect because the reverse distributor has independent recordkeeping and reporting obligations. B is incorrect because a receipt of transfer alone does not confirm destruction; the pharmacy needs documentation establishing the substances were ultimately destroyed. D is incorrect because the pharmacy must maintain its own records of the transfer and subsequent disposition.

Question 20

Which DEA form is used to document the destruction of controlled substances?

  1. DEA Form 222, which is used for ordering and destruction.
  2. DEA Form 106, which is used to report controlled substance theft and destruction.
  3. DEA Form 224, which is the pharmacy registration application.
  4. DEA Form 41, which is specifically used to document the destruction of controlled substances. (correct answer)
Explanation: DEA Form 41 is the Registrant Record of Controlled Substances Destroyed, used to document on-site destruction of controlled substances by a registrant. D correctly identifies this form. A is incorrect because DEA Form 222 is used for ordering Schedule I and II controlled substances, not destruction. B is incorrect because DEA Form 106 is used to report theft or significant loss, not destruction. C is incorrect because DEA Form 224 is the application for retail pharmacy DEA registration, not a destruction form.